Literature DB >> 29337030

Nasal IL-25 predicts the response to oral corticosteroids in chronic rhinosinusitis with nasal polyps.

Haiyu Hong1, Fenghong Chen2, Yueqi Sun2, Qintai Yang3, Wenxiang Gao2, Yujie Cao2, Yunping Fan4, Jianbo Shi5, Huabin Li6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29337030     DOI： 10.1016/j.jaci.2017.10.050

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  9 in total

1.  Fungal extracts stimulate solitary chemosensory cell expansion in noninvasive fungal rhinosinusitis.

Authors:  Neil N Patel; Vasiliki Triantafillou; Ivy W Maina; Alan D Workman; Charles C L Tong; Edward C Kuan; Peter Papagiannopoulos; John V Bosso; Nithin D Adappa; James N Palmer; Michael A Kohanski; De'Broski R Herbert; Noam A Cohen
Journal:  Int Forum Allergy Rhinol       Date:  2019-03-20       Impact factor: 3.858

2.  Increased TSLP, IL-33, IL-25, IL-19, IL 21 and amphiregulin (AREG) levels in chronic rhinosinusitis with nasal polyp.

Authors:  Murat Dogan; Mustafa Sahin; Cigdem Yenisey
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-03-19       Impact factor: 2.503

Review 3.  Sentinels at the wall: epithelial-derived cytokines serve as triggers of upper airway type 2 inflammation.

Authors:  Neil N Patel; Michael A Kohanski; Ivy W Maina; Alan D Workman; De'Broski R Herbert; Noam A Cohen
Journal:  Int Forum Allergy Rhinol       Date:  2018-09-10       Impact factor: 3.858

4.  Identification of multiple isoforms of glucocorticoid receptor in nasal polyps of patients with chronic rhinosinusitis.

Authors:  Shan Shao; Yue Wang; Yan Zhao; Yuan Xu; Tie Wang; Kun Du; Shiping Bao; Xiangdong Wang; Luo Zhang
Journal:  J Otolaryngol Head Neck Surg       Date:  2022-06-11

5.  Solitary chemosensory cells producing interleukin-25 and group-2 innate lymphoid cells are enriched in chronic rhinosinusitis with nasal polyps.

Authors:  Neil N Patel; Michael A Kohanski; Ivy W Maina; Vasiliki Triantafillou; Alan D Workman; Charles C L Tong; Edward C Kuan; John V Bosso; Nithin D Adappa; James N Palmer; De'Broski R Herbert; Noam A Cohen
Journal:  Int Forum Allergy Rhinol       Date:  2018-05-09       Impact factor: 3.858

Review 6.  Type 2 immunity-driven diseases: Towards a multidisciplinary approach.

Authors:  Dorian Hassoun; Olivier Malard; Sébastien Barbarot; Antoine Magnan; Luc Colas
Journal:  Clin Exp Allergy       Date:  2021-10-15       Impact factor: 5.401

7.  Transcriptomic and Lipidomic Profiles in Nasal Polyps of Glucocorticoid Responders and Non-Responders: Before and After Treatment.

Authors:  Zhenzhen Zhu; Weiqing Wang; Yang Zha; Xiaowei Wang; Lei Wang; Jinbo Han; Jianmin Zhang; Wei Lv
Journal:  Front Pharmacol       Date:  2022-01-13       Impact factor: 5.810

8.  Induction of IL-25 Expression in Human Nasal Polyp Epithelium by Influenza Virus Infection is Abated by Interferon-Alpha Pretreatment.

Authors:  Haiyu Hong; Kai Sen Tan; Yan Yan; Fenghong Chen; Hsiao Hui Ong; Yukei Oo; Jing Liu; Yew Kwang Ong; Mark Thong; Richard Sugrue; Vincent T Chow; De Yun Wang
Journal:  J Inflamm Res       Date:  2021-06-28

Review 9.  Innate Lymphoid Cells in the Airways: Their Functions and Regulators.

Authors:  Keisuke Orimo; Hirohisa Saito; Kenji Matsumoto; Hideaki Morita
Journal:  Allergy Asthma Immunol Res       Date:  2020-05       Impact factor: 5.764
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.